SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Appropriations | ₹105 Cr | ₹79 Cr | ₹62 Cr | ₹1,709,353 Cr | ₹17 Cr |
What is the latest Appropriations of SYNCOM FORMULATIONS (INDIA) ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹105 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹1,709,353 Cr |
| Mar2017 | ₹17 Cr |
How is Appropriations of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹105 Cr | 31.90 | |
| Mar2024 | ₹79 Cr | 27.77 | |
| Mar2023 | ₹62 Cr | -100.00 | |
| Mar2022 | ₹1,709,353 Cr | 9,801,799.59 | |
| Mar2017 | ₹17 Cr | - | |
Compare Appropriations of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,882.8 Cr | 6.5% | 16.4% | 13.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 6.5% |
16.4% |
13.2% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses